Skip to content

Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00660712
Enrollment
1018
Registered
2008-04-17
Start date
2008-03-31
Completion date
2009-03-31
Last updated
2009-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder

Keywords

Bipolar disorder, patient characteristics, treatment characteristics

Brief summary

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients previously or currently diagnosed with bipolar disorder * Patients (or any of their relatives) who give a written informed consent.

Exclusion criteria

* Patients who were previously included in this study.

Design outcomes

Primary

MeasureTime frame
Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Secondary

MeasureTime frame
Identification of the number of first degree relatives diagnosed with bipolar disorder
Evaluation of the relationship between patient and disease characteristics
Evaluation of the time period that elapsed since the diagnosis of bipolar disorder
Evaluation of co-morbid psychiatric diseases
Identification of treatment modalities selected according to the disease phase

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026